| Dr Susan Kim, MD | |
|
234 E 149th St, Bronx, NY 10451-5504 | |
| (718) 579-5734 | |
| (718) 579-4963 |
| Full Name | Dr Susan Kim |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 26 Years |
| Location | 234 E 149th St, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154496958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 214422 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lincoln Medical & Mental Health Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Downtown Bronx Medical Associates Pc | 9638082746 | 351 |
News Archive
Bristol-Myers Squibb Canada is pleased to announce that the Ontario government has made ERBITUX(TM) (cetuximab) available to patients suffering from metastatic colorectal cancer. This decision makes Ontario the second province, after British Columbia, to introduce funding for this important treatment option and represents encouraging news for those patients who rely on provincial drug coverage and stopped responding to standard treatments for metastatic colon cancer.
The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has received the Provectus Award presented by MDB Capital Group at the first annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property (IP).
A network of hundreds of doctors has uncovered the biological characteristics of 31 previously unknown diseases and provided diagnoses for many unsolved cases.
› Verified 5 days ago
| Entity Name | Downtown Bronx Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689618407 PECOS PAC ID: 9638082746 Enrollment ID: O20031106000016 |
News Archive
Bristol-Myers Squibb Canada is pleased to announce that the Ontario government has made ERBITUX(TM) (cetuximab) available to patients suffering from metastatic colorectal cancer. This decision makes Ontario the second province, after British Columbia, to introduce funding for this important treatment option and represents encouraging news for those patients who rely on provincial drug coverage and stopped responding to standard treatments for metastatic colon cancer.
The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has received the Provectus Award presented by MDB Capital Group at the first annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property (IP).
A network of hundreds of doctors has uncovered the biological characteristics of 31 previously unknown diseases and provided diagnoses for many unsolved cases.
› Verified 5 days ago
| Entity Name | Harlem Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487957692 PECOS PAC ID: 9335321223 Enrollment ID: O20110315000005 |
News Archive
Bristol-Myers Squibb Canada is pleased to announce that the Ontario government has made ERBITUX(TM) (cetuximab) available to patients suffering from metastatic colorectal cancer. This decision makes Ontario the second province, after British Columbia, to introduce funding for this important treatment option and represents encouraging news for those patients who rely on provincial drug coverage and stopped responding to standard treatments for metastatic colon cancer.
The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has received the Provectus Award presented by MDB Capital Group at the first annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property (IP).
A network of hundreds of doctors has uncovered the biological characteristics of 31 previously unknown diseases and provided diagnoses for many unsolved cases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Kim, MD 316 Franklin Ct, Edgewater, NJ 07020-1603 Ph: (201) 313-1993 | Dr Susan Kim, MD 234 E 149th St, Bronx, NY 10451-5504 Ph: (718) 579-5734 |
News Archive
Bristol-Myers Squibb Canada is pleased to announce that the Ontario government has made ERBITUX(TM) (cetuximab) available to patients suffering from metastatic colorectal cancer. This decision makes Ontario the second province, after British Columbia, to introduce funding for this important treatment option and represents encouraging news for those patients who rely on provincial drug coverage and stopped responding to standard treatments for metastatic colon cancer.
The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced that it has received the Provectus Award presented by MDB Capital Group at the first annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property (IP).
A network of hundreds of doctors has uncovered the biological characteristics of 31 previously unknown diseases and provided diagnoses for many unsolved cases.
› Verified 5 days ago
Selina Sultana Zaman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Nephrology Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |